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In March  2012,  the  SAGE  Working  Group  on  Vaccine  Hesitancy  was  convened  to define  the  term  “vaccine
hesitancy”,  as  well  as to map  the  determinants  of  vaccine  hesitancy  and  develop  tools  to  measure  and
address the  nature  and  scale  of hesitancy  in  settings  where  it is  becoming  more  evident.
The  definition  of  vaccine  hesitancy  and  a matrix  of  determinants  guided  the  development  of  a  survey
tool  to assess  the  nature  and  scale  of  hesitancy  issues.  Additionally,  vaccine  hesitancy  questions  were
piloted  in  the annual  WHO-UNICEF  joint  reporting  form,  completed  by National  Immunization  Managers
globally.  The  objective  of characterizing  the  nature  and  scale  of  vaccine  hesitancy  issues  is  to better inform
the development  of appropriate  strategies  and  policies  to  address  the  concerns  expressed,  and  to sustain
confidence  in  vaccination.The  Working  Group  developed  a matrix  of the  determinants  of vaccine  hesitancy  informed  by  a sys-
tematic  review  of peer  reviewed  and  grey  literature,  and  by  the  expertise  of  the  working  group.  The
matrix  mapped  the  key  factors  influencing  the  decision  to  accept,  delay  or reject some  or  all  vaccines
under  three  categories:  contextual,  individual  and  group,  and  vaccine-specific.  These  categories  framed
the menu  of survey  questions  presented  in this  paper  to help  diagnose  and  address  vaccine  hesitancy.
d  by  © 2015  Publishe
. Introduction
Despite compelling evidence of the value of vaccines in pre-
enting disease and disability and in saving the lives of millions of
hildren every year, vaccine hesitancy has become a growing focus
f attention and concern [1–3], given its potential to lead to vaccine
elays and refusals, and to risk the public health consequences of
accine preventable disease outbreaks.Please cite this article in press as: Larson HJ, et al. Measuring vaccin
http://dx.doi.org/10.1016/j.vaccine.2015.04.037
Research to date has shown that the reasons for and expressions
f vaccine hesitancy are highly varied [4–7] and need to be better
nderstood in order to appropriately address emerging concerns.
∗ Corresponding author at: Department of Infectious Disease Epidemiology, Lon-
on School of Hygiene & Tropical Medicine, London, United Kingdom.
E-mail address: Heidi.Larson@lshtm.ac.uk (H.J. Larson).
1 Member of SAGE Working Group on Vaccine Hesitancy.
2 Members of SAGE Working Group on Vaccine Hesitancy are listed in Appendix
.
ttp://dx.doi.org/10.1016/j.vaccine.2015.04.037
264-410X/© 2015 Published by Elsevier Ltd. This is an open access article under the CC BElsevier  Ltd. This  is  an  open  access  article  under  the  CC  BY license  (http://
creativecommons.org/licenses/by/3.0/).
Reasons for hesitancy can vary depending on the particular vaccine
or vaccines in question, the individuals or groups expressing reluc-
tance, and the context. Tools are needed to assess the scope and
scale of hesitancy issues by vaccine and setting. Ideally, a common
survey tool that can be used globally would allow comparability
across countries.
The varied reasons for vaccine hesitancy have been mapped by
the WHO  Strategic Advisory Group on Experts (SAGE) on Immu-
nization and the following definition of vaccine hesitancy was
developed:
“Vaccine hesitancy refers to a delay in acceptance or refusal of
vaccination despite availability of vaccination services. Vaccine
hesitancy is complex and context specific, varying across time,
place, and vaccines. It is influenced by factors such as compla-e hesitancy: The development of a survey tool. Vaccine (2015),
cency, convenience and confidence” [8].
Given that vaccine hesitancy is specific to sub-groups within
populations and is rarely population-wide, it is important to first
understand who is hesitant about vaccination, what their concerns
Y license (http://creativecommons.org/licenses/by/3.0/).
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Table 1
Questions of the PACV survey, by category (adapted from Opel 2011(13)).
Immunization behaviour
Have you ever delayed having your child get a shot for reasons other than
illness or allergy?
Have you ever decided not to have your child get a shot for reasons other
than illness or allergy?
How sure are you that following the recommended shot schedule is a good
idea for your child?
Do you agree with the following statement? It is my  role as a parent to
question shots.
If  you had another infant today, would you want him/her to get all the
recommended shots?
Overall, how hesitant about childhood shots would you consider yourself to
be?
Beliefs about vaccine safety and efficacy
Do you agree with the following beliefs about vaccine safety and efficacy?
Children get more shots than are good for them.
Many of the illnesses that shots prevent are severe.
It is better for my child to develop immunity by getting sick than by
getting a shot.
It is better for children to get fewer vaccines at the same time.
How concerned are you that your child might have a serious side effect from
a  shot?
How concerned are you that any one of the childhood shots might not be
safe?
How concerned are you that a shot might not prevent the disease?
Do you know of anyone who has had a bad reaction to a shot?
General attitudes and trust
Which of the following statements reflect your general attitude and trust
towards vaccines?
The only reason I have my child get shots is so that they can enter day-care
or  school.
I trust the information I receive about shots.
I  am able to openly discuss my  concerns about shots with my child’sARTICLEVAC-16369; No. of Pages 11
 H.J. Larson et al. / Va
re – i.e. which of the various possible reasons outlined above
re driving their hesitancy, and where the hesitant individuals are
ocated, i.e. in which geographic, socio-cultural or political context
hat may  be contributing to the hesitancy. Not all vaccine hesitancy
s specific to a vaccine or vaccination, and some influences are well
eyond the scope of an immunization programme, however they
ust be understood in order to know how to best minimize the
esitancy.
This paper presents a set of survey questions which were devel-
ped following an initial review of existing vaccine hesitancy
urveys, and consultations within the SAGE Vaccine Hesitancy
orking Group as well as with SAGE members [9]. Additionally,
roposed vaccine hesitancy questions for inclusion in the WHO-
NICEF Joint Reporting Form (JRF) [10] on immunization, which are
ompleted by national immunization programme managers annu-
lly, were explored as another opportunity to capture an indication
f the nature and scope of vaccine hesitancy at the national level.
In 2003, in order to begin to understand the scale of emerg-
ng vaccine concerns, one pilot question was included in the JRF,
sking national immunization managers whether they had to man-
ge negative media coverage about vaccines in the previous year.
he 2004 JRF report [10] showed that negative media coverage was
eported by countries in all WHO  regions except in South-East Asia.
he Americas and the European regions reported the highest levels
f negative publicity about vaccines (30% of the countries in those
egions). This initial survey question pointed to the scale of vaccine
esitancy already emerging over a decade ago. In the context of the
lobal Vaccine Action Plan (2011–2020) [11] and the SAGE work
n vaccine hesitancy, new questions were considered and piloted
or inclusion in the JRF in 2012, 2013 and 2014. While these JRF
uestions are limited in scope, they can serve as a valuable routine
ndicator of vaccine hesitancy in the population and point to areas
here more in-depth research is needed.
In the feedback from the regions and countries concerning the
012 JRF Indicators and the Immunization Managers’ Survey [12]
any countries called for a list of survey questions to help them
ssess vaccine hesitancy. More detailed survey questions identi-
ed through the SAGE process, discussed below, are an additional
esource to more specifically understand who is hesitating and
hat the nature of the concerns are, in order to inform an appro-
riate response.
. Methods
As part of the national JRFs completed annually, two indica-
ors for vaccine hesitancy were pilot-tested in the Americas and
he European WHO  regions. The two indicators were also tested
n a self-administered questionnaire distributed at the East, South
nd Central African Regional Immunization Managers’ meetings in
013. Pilot-testing the feasibility of these indicators within these
arious regions allowed for input from a broad range of high, mid-
le and low-income countries. The questions were accompanied
y the definition of vaccine confidence and prepared in English,
rench, Russian, and Spanish versions.
In the 2012 JRF pilot test, the focus was on vaccine confidence,
ather than on the broader issues driving vaccine hesitancy, in order
o be in harmony with the Global Vaccine Action Plan indicators.
pecifically, the indicators for Strategic Objective 2: “Individuals
nd communities understand the value of vaccines and demand
mmunization both as a right and a responsibility” are: (1) “Per-
entage of countries that have assessed (or measured) confidencePlease cite this article in press as: Larson HJ, et al. Measuring vaccin
http://dx.doi.org/10.1016/j.vaccine.2015.04.037
n vaccination at subnational level”, and (2) “Percentage of un- and
nder-vaccinated in whom lack of confidence was a factor that
nfluenced their decision.” Modifications to the 2013 JRF included
efining the indicators to encompass the wider scope of vaccine
’doctor.
All things considered, how much do you trust your child’s doctor?
hesitancy reasons going beyond confidence to also include con-
venience and complacency, and to link with the revised Working
Group definition of vaccine hesitancy.
2.1. 2013 JRF indicator revisions
2.1.1. Reasons for vaccine hesitancy
Question 1: What are the top three reasons for not accepting
vaccines according to the national schedule?
Question 2: Is this response based on or supported by some type
of assessment, or is it an opinion based on your knowledge and
expertise?
2.1.2. Process indicator
Question 1: Has there been some assessment of vaccine hesi-
tancy or refusal among the public at the national or sub-national
level?
Question 2: If yes, please provide assessment title(s) and refer-
ence(s) to any publication/report.
Parallel to the piloting of questions in the JRF, additional survey
questions were collected to inform a more detailed survey tool.
A review was undertaken to identify all survey questions and
tools mentioned in the articles collected in a systematic review of
literature conducted on vaccine hesitancy [3]. A selection of articles
(n = 2933) were re-screened for this purpose.
Keyword searches included: Search 1: ‘Survey’ and any
one of ‘accept/barrier/refus/trust/missed/delay/confidence/
partial/unsure/timeliness/hesitan’
Search 2: ‘Scale/Index/measurement/instrument/Questionnairee hesitancy: The development of a survey tool. Vaccine (2015),
and any one of ‘Trust/Confidence/Hesitan’
These keywords were chosen to identify either complete sur-
veys or survey items that reflect the concern of vaccine hesitancy.
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. Results
.1. The JRF
The response rate to the first JRF pilot in 2012 was  sub-optimal
ith only 14% (13/94) of countries completing the questions. The
nalysis revealed that 19% of all participating countries had done
n assessment of the level of confidence in their country, indicating
hat vaccine confidence was an issue of concern in their country. In
he assessments reported, lack of vaccine confidence ranged from
% in Cuba, Dominica, Botswana and Sao Tomé & Principe, 1% in
ermany and Brazil, 4% in Guatemala and Jamaica, 5% in Burundi, 8%
n the Democratic Republic of Congo, and 10% in Romania, to 18% in
zech Republic and 19% in Uganda. These results demonstrate that
he lack of confidence can be a significant problem, even in low-
ncome settings, such as Uganda, where suboptimal availability of
ervices might be presumed to be the reason for under-vaccination
ather than lack of confidence.
For the 2013 revision, 69% of countries (31/45) reported on
ndicator 1, which is a higher response rate to the indicator as com-
ared to 52% (25/48) in the JRF 2012. In the 2013 JRF, 10 countries
ndicated having undertaken an assessment. This may  be due toPlease cite this article in press as: Larson HJ, et al. Measuring vaccin
http://dx.doi.org/10.1016/j.vaccine.2015.04.037
n increased number of assessments among the countries in the
HO European region, better understanding of the question due
o the inclusion of a revised narrative, and/or the inclusion of both
able 2
ontextual influences.
Contextual influences (a) Communi-
cation and
media
environment
(b) Influential
leaders,
gatekeepers
and anti- or
pro-
vaccination
lobbies
(c) Historical
influences
Influences arising due
to historical,
socio-cultural,
environmental,
health systemic or
institutional,
economic or political
factors
What is the
most common
information
source you turn
to for
information on
vaccines?
Some groups or
leaders do not
agree to
vaccination for
different
reasons
Do you
remember any
events in the
past that would
have
discouraged
you from
getting a
vaccine(s) for
yourself or
your children?
When  you hear
a negative
comment
about
vaccine(s), do
you: Ask a
friend what
they think? Ask
a health
worker? Ask a
family or other
relative? Go to
the internet?
Other?
Do you know of
any of these
groups or
individuals?
If yes, please
describe the
event(s)
Whom do you
trust the most
for
information?
In general, do
you agree or
disagree with
these groups?
Whom do you
trust the least? PRESS
xxx (2015) xxx–xxx 3
a national and a sub-national assessment in the indicator question
in comparison to only a sub-national assessment in 2012. For those
countries not responding to indicator 1, it remains unclear if non-
response was  a proxy for no assessment, lack of understanding, or
lack of willingness to answer the question.
With regard to Indicator 2, in the 2013 pilot test, 36% (16/45)
of the countries responded to the question and provided reasons
for vaccine hesitancy. The response rate to this newly revised
indicator was  higher compared to the 2012 indicator where only
6% (3 out of 48) of the European region countries in 2012 had
provided a measured or estimated percentage of un- or under-
vaccinated in whom a lack of confidence in vaccination was  a
factor.
The top three reasons for vaccine hesitancy reported in the 2013
JRF were (1) beliefs, attitudes, motivation about health and pre-
vention, (2) risk/benefit of vaccines (perceived risks, experiences
(heuristics)), and (3) communication and media environment.
Major issues were fear of side effects of vaccination and distrust in
the vaccine, lack of perceived risk of vaccine-preventable diseases
and the influence anti-vaccination reports in the media.e hesitancy: The development of a survey tool. Vaccine (2015),
One hundred and eight articles were reviewed for survey ques-
tions and 10 articles included complete survey tools on vaccine
hesitancy, confidence or trust:
(d) Reli-
gion/culture/
gender/socio-
economic
influences
(e) Politics or
policies
(f) Geographic
barriers
(g)
Pharmaceutical
industry
influences
Do you know
anyone who
does not take a
vaccine
because of
religious or
cultural
reasons?
Do you trust
that your
government is
making
decision in
your best
interest with
respect to what
vaccines are
provided?
If you have to
spend more
than one hour
in travel time
to get a
vaccine, do you
consider it
important
enough to
travel for it?
Do you believe
that vaccine
producers are
interested in
your health?
Do you think
they are risking
their health or
the health of
their child if
they do not
take a vaccine?
Do you think
vaccinations
should be
compulsory or
not?
What is the
maximum
amount of time
you would be
able or willing
to spend to get
a vaccine for
yourself or
your children?
Do you trust
them to
provide safe
and effective
vaccines?
Do you think
any vaccines
are more
important for
boys/men?
Are there other
geographical
factors that
might prevent
you from
getting a
vaccine?
Do you think
any vaccines
are more
important for
girls/women?
ARTICLE IN PRESSG ModelJVAC-16369; No. of Pages 11
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Table 3
Individual and Group Influences.
Individual and group
influences
(a) Experience
with past
vaccination
(b) Beliefs,
attitudes about
health and
prevention
(c) Knowledge
awareness
(d) Health
system and
providers’ trust
and personal
experience
(e) Risk/benefit
(perceived,
heuristic)
(f)
Immunization
as a social
norm vs. not
needed/harmful
Influences arising from
personal perception
of the vaccine or
influences of the
social/peer
environment
Have you ever
not accepted a
vaccination for
your child?
Can you tell me
what a vaccine
is?
Do you feel
that you know
which vaccines
you should get
for yourself?
Your children?
Are you
satisfied with
your health
profes-
sional/health
worker’s
answers to
your questions
related to
immunization?
Do you
remember
which vaccines
you have
received? Or
which diseases
you have
received
vaccinations
for?
Do you think it
is important for
everyone to get
the
recommended
vaccines for
themselves and
their children?
Have  you ever
decided to not
get a
vaccination for
yourself?
What does it do
to the body?
Have you heard
about the HPV
vaccines?
Do you trust
the vaccine
advice your
health care
provider gives
you?
Do you
remember
which vaccines
your children
have gotten?
Please name
them.
If not, please
explain.
What was the
reason?
Do you believe
that there are
other (better)
ways to
prevent
diseases which
can currently
be prevented
by a vaccine?
Do you think
the polio
vaccine is still
needed?
Do you feel that
your health
care provider
cares about
what is best for
your child?
Which vaccines
do you think
are the most
important?
Do  you know
anyone who
has had a bad
reaction to a
vaccine?
Do you think
vaccines
strengthen the
immune
system?
Did you ever
experience an
AEFI (adverse
event following
immunization)
and if so, how
did the health
worker deal
with this?
Do you believe
vaccine
preventable
diseases can be
serious? Which
one(s)?
Do  you know
anyone who
has a child who
had a serious
disease
Do you think it
is possible to
have too many
vaccines?
Do you have
any concerns
about
vaccines? If so,
what are your
•
•
•
•
•
•
•
adapted by the Working Group to have more global relevance, given
that the tool was  developed and validated for a high-income settingbecause they
were not
vaccinated?
Parent Vaccine Hesitancy – Vaccines
Attitudes about Childhood Vaccines Survey [13,14].
Immunization Hesitancy Survey [15].
Trust – Healthcare and Vaccines
Measuring Trust in Physicians [16].
Series of surveys with strong focus on trust in the influenza
vaccine using the Trust and Confidence Model and Protection
Motivation Theory [17].
Nine questions developed to assess patient-health provider trust
in post-partum mothers’ relationship [18].
The National (US) Network for Immunization Information (NNii)
Survey Instrument [19].
Confidence – Healthcare and other sectors
Healthcare Confidence Index [20]Please cite this article in press as: Larson HJ, et al. Measuring vaccin
http://dx.doi.org/10.1016/j.vaccine.2015.04.037
All vaccines
The Vaccine Safety, Attitudes, Training and communication
Project (VACSATC) present a list of core questions included inconcerns?
multiple surveys implemented across several European countries
[21].
The work of Opel et al. was among the first to develop and
validate a survey tool specific to vaccine hesitancy, the Parent Atti-
tudes About Childhood Vaccines (PACV) survey. The PACV was
originally developed by adapting items from previous surveys on
health beliefs, conducting focus groups to produce additional items,
submitting these items to a panel of immunization experts to
remove items unlikely to be useful, and pre-testing the product on
a group of parents. The result of this process was an 18-item survey
encompassing the domains: immunization behaviour, beliefs about
vaccine safety and efficacy, attitudes and trust [22]. This was then
refined using a cross-sectional survey of parents of 19–35 month
old children in a Washington State HMO1 to assess the metric’s
construct validity and reliability [23]. Below is the set of questionse hesitancy: The development of a survey tool. Vaccine (2015),
(Table 1).
1 Health Maintenance Organization (USA).
Please cite this article in press as: Larson HJ, et al. Measuring vaccine hesitancy: The development of a survey tool. Vaccine (2015),
http://dx.doi.org/10.1016/j.vaccine.2015.04.037
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Table  4
Vaccine/vaccination-specific issues.
Vaccine/vaccination-
specific
issues
(a)
Risk/benefit
(scientific
evidence)
(b) Intro-
duction of a
new
vaccines or
a  new for-
mulation
(c) Mode of
administration
(d) Design of
vaccination
program/mode
of delivery
(e)
Reliability
and/or
source of
vaccine
supply
(f) Vaccina-
tion
schedule
(g) Costs (h) Role of
healthcare
professionals
Directly related to
vaccine or
vaccination
Do you
believe
vaccines
are safe for
yourself?
For your
child/children?
For those in
your com-
munity?
What is the
first thing
you want
to know
when a
new
vaccine is
introduced
or
announced?
Do you prefer a
vaccine that is
injected, taken
orally, or with a
nasal spray?
Is access to
immunization
easy? Is it
conveniently
located? Is the
process of
being
immunized
welcoming?
Do you feel
confident
that the
health
centre or
doctor’s
office will
have the
vaccine you
need, when
you need
them?
Do you
know the
recom-
mended
vaccine
schedule?
Would the
cost of a
vaccine
prevent
you from
getting it,
even if you
felt you or
your child
needed it?
Has a
healthcare
professional
ever treated
you without
respect (e.g.
in regards to
your
appearance,
your
education,
cultural
background,
etc.) so that
you will
hesitate to
return to the
healthcare
facility?
Do  you feel
you get
enough
informa-
tion about
vaccines
and their
safety?
When a
new
vaccine is
introduced,
do you
want to be
the first to
get it?
Are there any
things that
could be done
to make it
easier for you
to get vaccines
(on time) for
yourself and
your children?
Are there
any
vaccines
that are
difficult for
you to get
because of
the
schedule?
Would you
be willing
to pay for it
privately?
Has your
healthcare
provider ever
advised you
that a certain
vaccine was
not
necessary?
Which
vaccine?
Would you
rather wait
and see
what other
people do?
Is it better
for a child
to have
multiple
vaccines in
one short
with fewer
injections
or to have
individual
vaccines?
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Fig. 1. Articles identified with ‘survey’ only and ‘survey’ +1 or more Keywords.
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Across all years, Search 1 identified 77 articles containing
he keywords ‘trust’, ‘confidence’, or ‘hesitan’ (Fig. 1). Search
 identified an additional 31 relevant articles. All 108 arti-
les [13,15,17–19,21,24–124] were reviewed for survey items
ertaining to the components of the SAGE Vaccine Hesitancy Model
f determinants.
The review of vaccine hesitancy research to identify specific
urvey questions revealed that much of the research on this
opic is largely on cognition-based features such as knowledge,
ttitudes and beliefs and draws on two commonly used health
ehaviour models: the Health belief Model and the Theory of
lanned Behaviour. Neither of these models adequately investigate
he significance of social, economic and/or environmental factors
s determinants of health behaviour, in this case vaccine hesitancy.
Questions that were identified through the literature search
ere then mapped against the key determinants identified
Tables 2–4) based on feedback from the Working Group, and were
resented at a meeting on December 2013 for further discussion
nd feedback. It was clear that a number of determinants of vaccine
esitancy were not adequately addressed in the identified survey
uestions documented in the literature review. It was also agreed
hat while the matrix was a useful approach to identifying gaps in
he questions, a more survey-ready format was needed for imple-
entation.
The Working Group developed a compendium of three different
ypes of survey questions (See Appendices): Core Closed Questions
Appendix A); Likert Scale Questions (Appendix B); and a set of
pen Ended Questions (Appendix C). Some were derived from pre-
iously validated questionnaires, albeit in high-income countries
nly, some came from experts in the field, and others are newly
roposed.
. Discussion
Routine monitoring of vaccine hesitancy, such as through the
RF, could play a valuable role in identifying vaccine concerns
arly, in order to address them. Strategies to address any identified
oncerns, though, need more in-depth understanding of the nature
f hesitancy, as well as who is hesitating. This more detailed under-
tanding will need further research which could be initially guided
y the menu of survey questions presented here, followed by addi-
ional qualitative research in areas where surveys do not provide
dequate information to inform appropriate interventions. A stan-
ardized compendium of both survey and determinants questions
ould also enable intra- and inter-country comparison of the preva-
ence of, and the major determinants leading to, vaccine hesitancy,
nd support global assessment.
When countries use questions presented in this paper to mon-
tor hesitancy, several points must be considered in question
election: (1) Refusal is not the same as hesitancy, i.e. counting only
accine refusers will not capture hesitancy; (2) Vaccine hesitancy is
efined as delay in acceptance or refusal of vaccines despite availabil-
ty of vaccine services [125] and it is therefore essential to assess the
ifferent reasons why people are under- or unvaccinated in a par-
icular setting to be able tackle vaccine hesitancy as distinct from
ccess issues; and (3) Vaccine hesitancy may  be specific to one or
ome, but not all, vaccines, so interpretation of surveys should notPlease cite this article in press as: Larson HJ, et al. Measuring vaccin
http://dx.doi.org/10.1016/j.vaccine.2015.04.037
eneralize findings to all vaccines unless that is stated in the sur-
ey response. All of the survey questions, whether from the general
urvey or from the determinant examples, need to be pilot tested
nd validated in all settings and then refined. PRESS
xxx (2015) xxx–xxx
Given the dynamic and changing nature of vaccine hesitancy,
the importance of ongoing monitoring cannot be overstated.
A survey which reveals little hesitancy this year may have a
different result next year. These trends need monitoring. Addi-
tionally, qualitative research to better understand the contextual
and socio-cultural influences that may  be contributing to vac-
cine hesitancy will be important in informing the most relevant
strategies to engage hesitant publics, health providers and policy
makers.
5. Limitations
As the term “vaccine hesitancy” is relatively new, the availabil-
ity of existing survey questions is limited. Most are predominately
designed for high-income settings, and few have been validated.
Furthermore, the questions identified do not address all the deter-
minants in the Vaccine Hesitancy Matrix and additional questions
will need to be developed and validated.
6. Conclusion
In the final report on the work on vaccine hesitancy, SAGE
“encouraged validation of the developed compendium of survey
questions on vaccine hesitancy, which have been assessed and val-
idated only in some high-income countries or not at all.” SAGE also
urged:
WHO  to develop capacity “for gaining behavioural insights that
can be applied in an integrated fashion for prevention of many
communicable and non-communicable diseases, as well as vaccine
hesitancy” and stressed that “this will require a multi-disciplinary
approach, involving sociologists, psychologists, anthropologists,
experts in social marketing, communication experts, and specific
disease and vaccine experts.”
The recommendation for bringing multiple disciplines together
to understand and address the complex, context specific and
dynamic nature of vaccine hesitancy – and its varied drivers of
complacency, convenience and confidence – needs to extend to
all immunization stakeholders from national immunization pro-
grammes and community based organizations to private sector
partners and research entities.
Publics are changing, embracing their rights to information,
and their rights to choice. A certain amount of questioning by
new parents, or parents faced with new vaccines or combina-
tions of vaccines, would be considered responsible. Keeping an
open dialogue is fundamental to building trust. These survey tools
are primarily aimed to better understand the public concerns
and thereby better respond to the issues that are relevant to
them.
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ppendix A. Vaccine hesitancy survey questions: version 1.0
Questions to consider in assessing vaccine hesitancy at a
community level
To be asked to parents/caregivers about childhood
vaccinations
1.  Do you believe that vaccines can protect children from serious diseases?
Y/N
2.  Do you think that most parents like you have their children vaccinated
with all the recommended vaccines? Y/N
3.  Have you ever been reluctant or hesitated to get a vaccination for your
child? Y/N
4. Have you ever refused a vaccination for your child? Y/N
5.  If response is “yes” to questions 3 or 4:
Please check (
√
) which one(s):
Vaccine names Hesitated Refused
Chickenpox vaccine
Haemophilus influenzae b (Hib) Vaccine
Hepatitis B vaccine
Human papilloma virus (HPV) vaccine
Influenza vaccine
Polio vaccine
Measles vaccine
Meningococcal vaccine
Mumps  vaccine
Rubella vaccine
“Pentavalent” or other combination infant vaccine
Pneumococcal vaccine
Rotavirus vaccine
Tetanus, diphtheria, pertussis vaccine
What was/were the reason(s)? (Use list below to code response)
Reason Check (
√
) if applicable
Did  not think it was needed
Did not know where to get vaccination
Did not know where to get good/reliable information
Heard or read negative media
Did not think the vaccine was  effective
Did not think the vaccine was safe/concerned about side effects
Someone else told me  that the vaccine was  not safe
Had a bad experience with previous vaccinator/health clinic
Had a bad experience or reaction with previous vaccination
Someone else told me  they/their child had a bad reaction
Fear of needles
Not possible to leave other work (at home or other)
Religious reasons
Other beliefs/traditional medicine
Other (please specify):
6. Has distance, timing of clinic, time needed to get to clinic or wait at clinic,
and/or costs in getting to clinic prevented you from getting your child
immunized? Y/N
If  yes, please explain:
7.  Are there other pressures in your life that prevent you from getting your
child immunized on time? Y/N
If yes, please specify:
8.  Are there any reasons you can think of why  children should not be
vaccinated? Y/N
If yes, please specify:
9.  Do you think that it is difficult for some ethnic or religious groups in your
community/region to get vaccinations for their children? Y/N
If  yes, what do you think are the reason(s)?
Reason Check (
√
) if applicable
They  choose not to vaccinate
They do not feel welcome at the health service
Health services do not reach them
9. Have you ever received or heard negative information about vaccinations?
Y/N
If  yes,
a. Please give an example:
ab. Did you still take your child to get vaccinated after you heard the negative
information? Y/N
11.  Do leaders (religious or political leaders, teachers, health care workers) in
your community support vaccines for infants and children? Please indicate
below:
Leaders Check (
√
) if applicablePlease cite this article in press as: Larson HJ, et al. Measuring vaccine hesitancy: The development of a survey tool. Vaccine (2015),
http://dx.doi.org/10.1016/j.vaccine.2015.04.037
Religious
Political
Teachers
Health care workers
Other, please specify:
G Model
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ppendix B. Vaccine hesitancy 5 point likert scale questions
Vaccine Hesitancy 5 point Likert
scale questions:
How much do you agree with the
each of the following
statement on vaccinations?
Please indicate your response
with a check mark (
√
) in the
appropriate box, using the
scale below:
SCALE:
1  = strongly disagree
2  = disagree
3 = neither agree nor disagree
4 = agree
5 = strongly agree
1 2 3 4 5
L1.  Childhood vaccines are
important for my child’s
health
L2. Childhood vaccines are
effective
L3. Having my  child
vaccinated is important for
the health of others in my
community
L4. All childhood vaccines
offered by the government
programme in my
community are beneficial.
L5. New vaccines carry
more risks than older
vaccines
L6. The information I
receive about vaccines
from the vaccine program
is reliable and trustworthy.
L7. Getting vaccines is a
good way to protect my
child/children from
disease.
L8. Generally I do what my
doctor or health care
provider recommends
about vaccines for my
child/children.
L9. I am concerned about
serious adverse effects of
vaccines.
L10. My child/children
does or do not need
vaccines for diseases that
are not common anymore.
ppendix C. Vaccine hesitancy open ended survey questions
Vaccine Hesitancy Open Ended Survey Questions
Name of Respondent (Parent/Guardian): Name of Reviewer:
Respondent’s Age: Respondent’s Gender:
Number of children under the care of the Respondent:
Age of the youngest child under the care of the Respondent:
Immunization status of the youngest child under the care of the Respondent: Fully vaccinated for age/Partially vaccinated for
age/Unvaccinated
Question 1: Dear Parent/Guardian, what are the 3 major reasons why you should immunize your child? (Reviewer, please list them below in the
order of priority).
Question 2: Dear Parent/Guardian, Do you have any worries or concerns when you take your child for immunization? Y/N
If  yes, what are they? (Please list them below in the order of priority).
Question 3: (ask this question only for Parent/Guardians who  are known to have accepted immunization in the last 1 year) Dear
Parent/Guardian, in your family, what was the reason behind your decision to vaccinate your child (Name XYZ) last week/month/year? (Please
list  them below in the order of priority).Please cite this article in press as: Larson HJ, et al. Measuring vaccine hesitancy: The development of a survey tool. Vaccine (2015),
http://dx.doi.org/10.1016/j.vaccine.2015.04.037
Question 4: (ask this question only for Parent/Guardians who  are known to have refused immunization in the last 1 year) Dear
Parent/Guardian, in your family, what was the reason behind your decision NOT to vaccinate your child (Name XYZ) last week/month/year?
(Please list them below in the order of priority).
Question 5: Dear Parent/Guardian, in your personal opinion, why  do some persons refuse to vaccinate their children?
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